Rite Aid Expands Naloxone Dispensing Program in Six Additional States
February 15 2017 - 9:23AM
Business Wire
Naloxone Available Without a Prescription at
Pharmacies in Georgia, Louisiana, Tennessee, Utah, Virginia and
West Virginia
Rite Aid announced today that naloxone, a medication that can be
used to reverse the effects of an opioid overdose, is now available
at more than 630 pharmacies in Georgia, Louisiana, Tennessee, Utah,
Virginia and West Virginia without a prescription, subject to state
regulations. Previously, naloxone, which can be administered by
injection or nasal spray, was only available with a physician’s
prescription.
“As the epidemic continues to grow, as evidenced in the Centers
for Disease Control and Prevention recent statistic, 91 people die
every day from an opioid overdose in the United States,” said
Jocelyn Konrad, Rite Aid executive vice president of pharmacy.
“With the ability to dispense naloxone without a prescription in
more than 20 states, Rite Aid is not only showing its commitment to
increasing customer access to this potentially lifesaving
medication, but we are also raising awareness and helping fight
drug abuse in the communities we serve.”
Naloxone is also available for purchase without patient specific
prescriptions at Rite Aid pharmacies in 17 additional states
including: Alabama, California, Colorado, Connecticut, Idaho,
Indiana, Kentucky, Massachusetts, Maryland, North Carolina, New
Hampshire, New York, Ohio, Oregon, Pennsylvania, Rhode Island and
Vermont.
To date, Rite Aid has trained more than 10,000 pharmacists on
naloxone dispensing. Rite Aid is also working to expand its
naloxone dispensing program in other states served by the Company
where naloxone is currently only available with a prescription.
Rite Aid Corporation (NYSE: RAD) is one of the nation's leading
drugstore chains with nearly 4,600 stores in 31 states and the
District of Columbia and fiscal 2016 annual revenues of $30.7
billion. Information about Rite Aid, including corporate background
and press releases, is available through the company's website at
www.riteaid.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170215005679/en/
Rite Aid CorporationMEDIA:Ashley Flower, 717/975-5718
Rite Aid (NYSE:RAD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Rite Aid (NYSE:RAD)
Historical Stock Chart
From Apr 2023 to Apr 2024